Table of Contents
ISRN Microbiology
Volume 2012 (2012), Article ID 186915, 5 pages
http://dx.doi.org/10.5402/2012/186915
Research Article

Detection and Typing of Human Papilloma Virus by Multiplex PCR with Type-Specific Primers

FRP Genética, 115A Ote 1417-1, 72520 Puebla, PUE, Mexico

Received 12 October 2011; Accepted 23 November 2011

Academic Editors: T. Krishnan, A. Mirazimi, and N. Yamamoto

Copyright © 2012 Francisco Romero-Pastrana. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. D. M. Parkin and F. Bray, “Chapter 2: the burden of HPV-related cancers,” Vaccine, vol. 24, no. 3, pp. S11–S25, 2006. View at Publisher · View at Google Scholar · View at Scopus
  2. World Health Organization, “International Agency for Research on Cancer. GLOBOCAN database 2002,” CANCERMondial, 2002, http://www-dep.iarc.fr/.
  3. E. C. Lazcano-Ponce, P. Najera, P. Alonso de Ruiz, E. Buiatti, and M. Hernandez-Avila, “Programa de detección oportuna del cáncer cervical en México. I. Diagnóstico situacional,” Revista del Instituto Nacional de Cancerología, vol. 42, no. 3, pp. 123–140, 1996. View at Google Scholar
  4. Secretaría de Salud (Méx), Registro Histopatológico de Neoplasias en México, Secretaría de Salud, México D. F., Mexico, 1999.
  5. F. X. Bosch, A. Lorincz, N. Muñoz, C. J. L. M. Meijer, and K. V. Shah, “The causal relation between human papillomavirus and cervical cancer,” Journal of Clinical Pathology, vol. 55, no. 4, pp. 244–265, 2002. View at Google Scholar · View at Scopus
  6. S. Chichareon, R. Herrero, N. Muñoz et al., “Risk factors for cervical cancer in Thailand: a case-control study,” Journal of the National Cancer Institute, vol. 90, no. 1, pp. 50–57, 1998. View at Google Scholar · View at Scopus
  7. L. A. Koutsky, K. K. Holmes, C. W. Critchlow et al., “A cohort study of the risk of cervical intraepithelial neoplasia grade 2 or 3 in relation to papillomavirus infection,” The New England Journal of Medicine, vol. 327, no. 18, pp. 1272–1278, 1992. View at Google Scholar · View at Scopus
  8. M. Lehtinen, T. Luukkaala, K. L. Wallin et al., “Human papillomavirus infection, risk for subsequent development of cervical neoplasia and associated population attributable fraction,” Journal of Clinical Virology, vol. 22, no. 1, pp. 117–124, 2001. View at Publisher · View at Google Scholar · View at Scopus
  9. M. H. Schiffman, H. M. Bauer, R. N. Hoover et al., “Epidemiologic evidence showing that human papillomavirus infection causes most cervical intraepithelial neoplasia,” Journal of the National Cancer Institute, vol. 85, no. 12, pp. 958–964, 1993. View at Google Scholar · View at Scopus
  10. T. C. Wright, J. Thomas Cox, L. Stewart Massad, L. B. Twiggs, and E. J. Wilkinson, “2001 consensus guidelines for the management of women with cervical cytological abnormalities,” Journal of the American Medical Association, vol. 287, no. 16, pp. 2120–2129, 2002. View at Google Scholar · View at Scopus
  11. N. Muñoz, F. X. Bosch, S. De Sanjosé et al., “Epidemiologic classification of human papillomavirus types associated with cervical cancer,” The New England Journal of Medicine, vol. 348, no. 6, pp. 518–527, 2003. View at Publisher · View at Google Scholar · View at Scopus
  12. E. M. De Villiers, C. Fauquet, T. R. Broker, H. U. Bernard, and H. Zur Hausen, “Classification of papillomaviruses,” Virology, vol. 324, no. 1, pp. 17–27, 2004. View at Publisher · View at Google Scholar · View at Scopus
  13. A. Molijn, B. Kleter, W. Quint, and L. J. Van Doorn, “Molecular diagnosis of human papillomavirus (HPV) infections,” Journal of Clinical Virology, vol. 32, pp. S43–S51, 2005. View at Publisher · View at Google Scholar · View at Scopus
  14. M. Nishiwaki, T. Yamamoto, S. Tone et al., “Genotyping of human papillomaviruses by a novel one-step typing method with multiplex PCR and clinical applications,” Journal of Clinical Microbiology, vol. 46, no. 4, pp. 1161–1168, 2008. View at Publisher · View at Google Scholar · View at Scopus
  15. R. Kalendar, D. Lee, and A. H. Schulman, “FastPCR software for PCR primer and probe design and repeat search,” Genes, Genomes and Genomics, vol. 3, no. 1, pp. 1–14, 2009. View at Google Scholar
  16. D. A. Bell, J. A. Taylor, D. F. Paulson, C. N. Robertson, J. L. Mohler, and G. W. Lucier, “Genetic risk and carcinogen exposure: a common inherited defect of the carcinogen-metabolism gene glutathione S-transferase M1 (GSTM1) that increases susceptibility to bladder cancer,” Journal of the National Cancer Institute, vol. 85, no. 14, pp. 1159–1164, 1993. View at Google Scholar · View at Scopus
  17. P. E. Gravitt, C. L. Peyton, T. Q. Alessi et al., “Improved amplification of genital human papillomaviruses,” Journal of Clinical Microbiology, vol. 38, no. 1, pp. 357–361, 2000. View at Google Scholar · View at Scopus
  18. P. E. Gravitt and R. Jamshidi, “Diagnosis and management of oncogenic cervical human papillomavirus infection,” Infectious Disease Clinics of North America, vol. 19, no. 2, pp. 439–458, 2005. View at Publisher · View at Google Scholar · View at Scopus
  19. A. M. De Roda Husman, J. M. M. Walboomers, A. J. C. Van den Brule, C. J. L. M. Meijer, and P. J. F. Snijders, “The use of general primers GP5 and GP6 elongated at their 3' ends with adjacent highly conserved sequences improves human papillomavirus detection by PCR,” Journal of General Virology, vol. 76, no. 4, pp. 1057–1062, 1995. View at Google Scholar · View at Scopus
  20. M. V. Jacobs, P. J. F. Snijders, F. J. Voorhorst et al., “Reliable high risk HPV DNA testing by polymerase chain reaction: an intermethod and intramethod comparison,” Journal of Clinical Pathology, vol. 52, no. 7, pp. 498–503, 1999. View at Google Scholar · View at Scopus
  21. B. Kleter, L. J. Van Doorn, L. Schrauwen et al., “Development and clinical evaluation of a highly sensitive PCR-reverse hybridization line probe assay for detection and identification of anogenital human papillomavirus,” Journal of Clinical Microbiology, vol. 37, no. 8, pp. 2508–2517, 1999. View at Google Scholar · View at Scopus
  22. M. M. Manos, Y. Ting, D. K. Wright, A. J. Lewis, T. R. Broker, and S. M. Wolinski, “The use of polymerase chain reaction amplification for the detection of genital human papillomaviruses,” Cancer Cells, vol. 7, pp. 209–214, 1989. View at Google Scholar
  23. H. Yoshikawa, T. Kawana, K. Kitagawa, M. Mizuno, H. Yoshikura, and A. Iwamoto, “Detection and typing of multiple general human papillomaviruses by DNA amplification with consensus primers,” Japanese Journal of Cancer Research, vol. 82, no. 5, pp. 524–531, 1991. View at Google Scholar · View at Scopus
  24. G. Astori, A. Arzese, C. Pipan, E. M. De Villiers, and G. A. Botta, “Characterization of a putative new HPV genomic sequence from a cervical lesion using L1 consensus primers and restriction fragment length polymorphism,” Virus Research, vol. 50, no. 1, pp. 57–63, 1997. View at Publisher · View at Google Scholar · View at Scopus
  25. A. J. C. Van den Brule, R. Pol, N. Fransen-Daalmeijer, L. M. Schouls, C. J. L. M. Meijer, and P. J. F. Snijders, “GP5+/6+ PCR followed by reverse line blot analysis enables rapid and high-throughput identification of human papillomavirus genotypes,” Journal of Clinical Microbiology, vol. 40, no. 3, pp. 779–787, 2002. View at Publisher · View at Google Scholar · View at Scopus
  26. O. Lungu, T. C. Wright, and S. Silverstein, “Typing of human papillomaviruses by polymerase chain reaction amplification with L1 consensus primers and RFLP analysis,” Molecular and Cellular Probes, vol. 6, no. 2, pp. 145–152, 1992. View at Google Scholar · View at Scopus
  27. P. Kay, K. Meehan, and A. L. Williamson, “The use of nested polymerase chain reaction and restriction fragment length polymorphism for the detection and typing of mucosal human papillomaviruses in samples containing low copy numbers of viral DNA,” Journal of Virological Methods, vol. 105, no. 1, pp. 159–170, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. T. Iftner and L. L. Villa, “Chapter 12: human papillomavirus technologies,” Journal of the National Cancer Institute. Monographs, no. 31, pp. 80–88, 2003. View at Google Scholar · View at Scopus
  29. J. C. Feoli-Fonseca, L. L. Oligny, P. Brochu, P. Simard, S. Falconi, and W. V. Yotov, “Human papillomavirus (HPV) study of 691 pathological specimens from Quebec by PCR-direct sequencing approach,” Journal of Medical Virology, vol. 63, no. 4, pp. 284–292, 2001. View at Publisher · View at Google Scholar
  30. N. Speich, C. Schmitt, R. Bollmann, and M. Bollmann, “Human papillomavirus (HPV) study of 2916 cytological samples by PCR and DNA sequencing: genotype spectrum of patients from the west German area,” Journal of Medical Microbiology, vol. 53, no. 2, pp. 125–128, 2004. View at Publisher · View at Google Scholar · View at Scopus
  31. M. Almonte, C. Ferreccio, J. L. Winkler et al., “Cervical screening by visual inspection, HPV testing, liquid-based and conventional cytology in Amazonian Peru,” International Journal of Cancer, vol. 121, no. 4, pp. 796–802, 2007. View at Publisher · View at Google Scholar · View at Scopus